Related Experiment Videos
High sensitivity, homogeneous particle-based immunoassay for thyrotropin (Multipact)
T A Wilkins1, G Brouwers, J C Mareschal
1Acade Diagnostic Systems SA, Louvain La Neuve, Belgium.
Clinical Chemistry
|September 1, 1988
Summary
This study introduces a novel, nonradioactive particle immunoassay for human thyrotropin (TSH). The high-sensitivity assay offers accurate, precise, and rapid detection of TSH levels, comparable to existing methods.
Area of Science:
- Biochemistry
- Immunology
- Medical Diagnostics
Background:
- Thyrotropin (TSH) is a critical hormone for thyroid function.
- Existing high-sensitivity TSH assays often involve radioactivity or serum interferences.
- A need exists for a sensitive, nonradioactive TSH assay.
Purpose of the Study:
- To develop and validate a novel homogeneous, nonradioactive, high-sensitivity assay for human thyrotropin (TSH).
- To utilize particle immunoassay technology with fragmented monoclonal antibodies for improved performance.
- To compare the assay's performance against a leading commercial TSH assay.
Main Methods:
- Development of an 800-nm particle-based immunoassay.
- Use of fragmented monoclonal antibodies covalently coupled to particles.
- Semiautomated assay performance using the Multipact system.
- Validation through precision, sensitivity, and clinical correlation studies.
Main Results:
- The assay is homogeneous, nonradioactive, and highly sensitive.
- Equilibrium is reached in under 2 hours.
- The assay demonstrates accuracy, good precision at low concentrations, and comparable detection limits to a leading IRMA.
- Clinical correlation studies showed strong agreement with a reference IRMA method (r=0.98).
Conclusions:
- The developed particle immunoassay is a viable, high-sensitivity, nonradioactive method for human TSH measurement.
- The assay offers advantages in speed and reduced interference.
- This assay represents a significant advancement in TSH diagnostics.